Few prospective studies have documented the seropositivity among those children infected
with severe acute respiratory syndrome coronavirus 2. From 2 April 2021 to 24 June 2021 …

Background Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
seroprevalence studies largely focus on adults, but little is known about spread in children …

Background Case-based surveillance of pediatric coronavirus disease 2019 (COVID-19)
cases underestimates the prevalence of severe acute respiratory syndrome coronavirus 2 …

Importance As vaccines for children under the age of 12 are not yet approved, determining
the SARS-CoV-2 infection rate in children is important for decisions about protective …

ABSTRACT BACKGROUND Children (≤ 18 years) account for∼ 20% of the US population
but currently represent< 2% of coronavirus disease 2019 (COVID-19) cases. Because …

The estimated severe acute respiratory syndrome coronavirus 2 seroprevalence in children
was found to be 9.46% for the Washington Metropolitan area. Hispanic/Latinx individuals …

Background Pediatric SARS-CoV-2 data remain limited and seropositivity rates in children
were reported as< 1% early in the pandemic. Seroepidemiologic evaluation of SARS-CoV-2 …

Background Children infected with SARS-CoV-2 are often asymptomatic or have only mild
symptoms, leading to underestimation of disease prevalence in symptom-based testing …

Background Understanding the prevalence and clinical presentation of coronavirus disease
2019 in pediatric patients can help healthcare providers and systems prepare and respond …

Background: The burden of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
in asymptomatic children was initially presumed to be high, which influenced hospital …